Cargando…
From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease
The history of polyglutamine diseases dates back approximately 20 years to the discovery of a polyglutamine repeat in the androgen receptor of SBMA followed by the identification of similar expansion mutations in Huntington's disease, SCA1, DRPLA, and the other spinocerebellar ataxias. This com...
Autores principales: | Weber, Jonasz Jeremiasz, Sowa, Anna Sergeevna, Binder, Tina, Hübener, Jeannette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189765/ https://www.ncbi.nlm.nih.gov/pubmed/25309920 http://dx.doi.org/10.1155/2014/701758 |
Ejemplares similares
-
Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity
por: Incebacak Eltemur, Rana Dilara, et al.
Publicado: (2022) -
Editorial: The role of posttranslational modifications in polyglutamine diseases
por: Weber, Jonasz Jeremiasz, et al.
Publicado: (2023) -
Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
por: Nguyen, Huu Phuc, et al.
Publicado: (2013) -
Neurodegenerative phosphoprotein signaling landscape in models of SCA3
por: Sowa, Anna S., et al.
Publicado: (2021) -
Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination
por: Harmuth, Tina, et al.
Publicado: (2022)